Radiation/cisplatin combination established as standard of care for HPV+ oral cancer

(American Society for Radiation Oncology) Combinations of radiation and chemotherapy drugs have been shown to cure HPV-related head and neck cancer with a high success rate. A new phase III trial has now determined that cisplatin chemotherapy, combined with radiation therapy, produces the best results and should be considered the standard of care. Findings will be presented in a news briefing Tuesday at 3 p.m. ET from the American Society for Radiation Oncology (ASTRO) Annual Meeting.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news